Alert: Major Price Decline (9/16/21)-MacroGenics Inc (NASDAQ: MGNX).


MacroGenics Inc (NASDAQ: MGNX) stock closed at $20.99 on 9/16/21 after a major decline of -23.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 694% of normal. The stock has performed in line with the market over the last nine months and has declined -0.6% during the last week.


Current PriceTarget Research Rating

MGNX’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.

MacroGenics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. MacroGenics has a poor Power Rating of 25 and a very low Appreciation Score of 9, producing the Lowest Value Trend Rating.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.

About John Lafferty 103103 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.